Lexicon Pharmaceuticals LXRX
NASDAQ LXRX
$1.82 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lexicon Pharmaceuticals (LXRX) Non-Current Deffered Revenue (2010 - 2019)

Updated

Lexicon Pharmaceuticals (LXRX) posted Non-Current Deffered Revenue of $24.27 million for Q2 2019, up 33.4% from $18.2 million a year earlier but down 1.4% from the prior quarter.

Analysis

Lexicon Pharmaceuticals (LXRX) Non-Current Deffered Revenue (2010 - 2019) Analysis & Trends

At the end of FY2018, Lexicon Pharmaceuticals' Non-Current Deffered Revenue came in at $23.65 million, down 5.0% from FY2017.

  • Annual Non-Current Deffered Revenue has declined for three consecutive years, though with a five-year compound annual growth rate of 12.0% (FY2013 to FY2018).
  • In prior years, Lexicon Pharmaceuticals' Non-Current Deffered Revenue was $24.9 million in FY2017 (-49.1%), $48.93 million in FY2016 (-55.2%), $109.15 million in FY2015 (+760.9%) and $12.68 million in FY2014 (-5.4%).
  • Quarterly Non-Current Deffered Revenue has run from a low of $11.71 million in Q1 2015 to a high of $109.15 million in Q4 2015 over five years.
  • On a year-over-year basis, Non-Current Deffered Revenue increased in two of the last eight quarters, with an average decline of 17.7%.
  • The strongest year-over-year quarter for Non-Current Deffered Revenue in the past five years was Q1 2016, with growth of 777.2%; the weakest was Q1 2017, with a decline of 72.0%.
  • According to Business Quant data, Non-Current Deffered Revenue for the three prior quarters was $24.62 million (Q1 2019), $23.65 million (Q4 2018) and $20.99 million (Q3 2018).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Lexicon Pharmaceuticals 813.30 Mn 239.86 Mn 653,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 24.27 Mn
Mar 31, 2019 24.62 Mn
Dec 31, 2018 23.65 Mn
Sep 30, 2018 20.99 Mn
Jun 30, 2018 18.20 Mn
Mar 31, 2018 22.08 Mn
Dec 31, 2017 24.90 Mn
Sep 30, 2017 26.55 Mn
Jun 30, 2017 28.31 Mn
Mar 31, 2017 28.75 Mn
Dec 31, 2016 48.93 Mn
Sep 30, 2016 55.44 Mn
Jun 30, 2016 92.19 Mn
Mar 31, 2016 102.70 Mn
Dec 31, 2015 109.15 Mn
Sep 30, 2015 11.71 Mn
Jun 30, 2015 11.71 Mn
Mar 31, 2015 11.71 Mn
Dec 31, 2014 12.68 Mn
Sep 30, 2014 12.68 Mn
API Access

Lexicon Pharmaceuticals Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=LXRX&period=max&api_key=YOUR_API_KEY